{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:08:51Z","timestamp":1787771331729,"version":"build-2784847793"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Surg"],"DOI":"10.1186\/s12893-025-03136-9","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T02:45:33Z","timestamp":1756089933000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Real-world safety of irreversible electroporation therapy for tumors with nanoknife: MAUDE database analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Jia-Cheng","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Yu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Xuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Dong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"issue":"3","key":"3136_CR1","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1007\/s00330-024-11343-w","volume":"35","author":"BM Schaarschmidt","year":"2025","unstructured":"Schaarschmidt BM, Zensen S, Kesch C, Dertnig T, Opitz M, Drews M, Nadjiri J, Forsting M, Hadaschik BA, Haubold J. Current use of percutaneous ablation in renal tumors: an analysis of the registry of the German society for interventional radiology and minimally invasive therapy. Eur Radiol. 2025;35(3):1723\u201331.","journal-title":"Eur Radiol"},{"issue":"1","key":"3136_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-024-03614-z","volume":"22","author":"C Cheng","year":"2024","unstructured":"Cheng C, Xu M, Pan J, Chen Q, Li K, Xu D, Jing X, Lu Q, Yang H, Zhao Q, et al. A multicenter, randomized, parallel-controlled clinical trial protocol to evaluate the safety and efficacy of irreversible electroporation compared with radiofrequency ablation for the treatment of small hepatocellular carcinoma. World J Surg Oncol. 2024;22(1): 332.","journal-title":"World J Surg Oncol"},{"issue":"1","key":"3136_CR3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12885-025-13510-8","volume":"25","author":"F-Q Wei","year":"2025","unstructured":"Wei F-Q, Huang P-S, Zhang B, Guo R, Yuan Y, Chen J, Lin Z-Y. Refining MR-guided thermal ablation for HCC within the Milan criteria: a decade of clinical outcomes and predictive modeling at a single institution. BMC Cancer. 2025;25(1):159.","journal-title":"BMC Cancer"},{"issue":"7","key":"3136_CR4","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.jvir.2014.01.028","volume":"25","author":"HJ Scheffer","year":"2014","unstructured":"Scheffer HJ, Nielsen K, de Jong MC, van Tilborg AAJM, Vieveen JM, Bouwman ARA, Meijer S, van Kuijk C, van den Tol PMP, Meijerink MR. Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy. J Vasc Interv Radiol. 2014;25(7):997\u20131011.","journal-title":"J Vasc Interv Radiol"},{"issue":"2","key":"3136_CR5","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1148\/radiol.10090337","volume":"255","author":"EW Lee","year":"2010","unstructured":"Lee EW, Chen C, Prieto VE, Dry SM, Loh CT, Kee ST. Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation. Radiology. 2010;255(2):426\u201333.","journal-title":"Radiology"},{"issue":"3","key":"3136_CR6","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.euo.2019.04.008","volume":"3","author":"A Blazevski","year":"2020","unstructured":"Blazevski A, Scheltema MJ, Yuen B, Masand N, Nguyen TV, Delprado W, Shnier R, Haynes A-M, Cusick T, Thompson J, et al. Oncological and quality-of-life outcomes following focal irreversible electroporation as primary treatment for localised prostate cancer: a biopsy-monitored prospective cohort. Eur Urol Oncol. 2020;3(3):283\u201390.","journal-title":"Eur Urol Oncol"},{"key":"3136_CR7","doi-asserted-by":"crossref","unstructured":"Martin RCG, Kwon D, Chalikonda S, Sellers M, Kotz E, Scoggins C, McMasters KM, Watkins K. Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy. Ann Surg. 2015;262(3):486\u201392.","DOI":"10.1097\/SLA.0000000000001441"},{"issue":"2","key":"3136_CR8","doi-asserted-by":"publisher","first-page":"190","DOI":"10.14218\/JCTH.2021.00019","volume":"10","author":"Y Ma","year":"2022","unstructured":"Ma Y, Chen Z, Liang B, Li R, Li J, Li Z, Lin M, Niu L. Irreversible electroporation for hepatocellular carcinoma abutting the diaphragm: a prospective single-center study. J Clin Transl Hepatol. 2022;10(2):190\u20136.","journal-title":"J Clin Transl Hepatol"},{"issue":"5","key":"3136_CR9","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.hbpd.2022.08.006","volume":"21","author":"M Xu","year":"2022","unstructured":"Xu M, Xie L-T, Xiao Y-Y, Liang P, Zhao Q-Y, Wang Z-M, Chai W-L, Wei Y-T, Xu L-F, Hu X-K, et al. Chinese clinical practice guidelines for ultrasound-guided irreversible electroporation of liver cancer (version 2022). Hepatobiliary Pancreat Dis Int. 2022;21(5):462\u201371.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"17","key":"3136_CR10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006386","volume":"96","author":"T Lyu","year":"2017","unstructured":"Lyu T, Wang X, Su Z, Shangguan J, Sun C, Figini M, Wang J, Yaghmai V, Larson AC, Zhang Z. Irreversible electroporation in primary and metastatic hepatic malignancies: A review. Medicine. 2017;96(17): e6386.","journal-title":"Medicine"},{"issue":"4","key":"3136_CR11","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.amjsurg.2016.07.001","volume":"212","author":"P Kambakamba","year":"2016","unstructured":"Kambakamba P, Bonvini JM, Glenck M, Castrezana L\u00f3pez L, Pfammatter T, Clavien PA, DeOliveira ML. Intraoperative adverse events during irreversible electroporation-a call for caution. Am J Surg. 2016;212(4):715\u201321.","journal-title":"Am J Surg"},{"issue":"1","key":"3136_CR12","doi-asserted-by":"publisher","first-page":"116","DOI":"10.2478\/raon-2019-0011","volume":"53","author":"N Verloh","year":"2019","unstructured":"Verloh N, Jensch I, L\u00fcrken L, Haimerl M, Dollinger M, Renner P, Wiggermann P, Werner JM, Zeman F, Stroszczynski C, et al. Similar complication rates for irreversible electroporation and thermal ablation in patients with hepatocellular tumors. Radiol Oncol. 2019;53(1):116\u201322.","journal-title":"Radiol Oncol"},{"key":"3136_CR13","doi-asserted-by":"crossref","unstructured":"Martin RCG, White RR, Bilimoria MM, Kluger MD, Iannitti DA, Polanco PM, Hammil CW, Cleary SP, Heithaus RE, Welling T, et al. Effectiveness and Safety of Irreversible Electroporation When Used for the Ablation of Stage 3 Pancreatic Adenocarcinoma: Initial Results from the DIRECT Registry Study. Cancers (Basel). 2024;16(23):3894.","DOI":"10.3390\/cancers16233894"},{"issue":"3","key":"3136_CR14","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.surg.2023.08.042","volume":"175","author":"K Stephens","year":"2024","unstructured":"Stephens K, Philips PP, Egger ME, Scoggins CR, McMasters KM, Martin RCG. Multi-institutional review of adverse events associated with irreversible electroporation in the treatment of locally advanced pancreatic cancer. Surgery. 2024;175(3):704\u201311.","journal-title":"Surgery"},{"issue":"5","key":"3136_CR15","doi-asserted-by":"publisher","first-page":"541","DOI":"10.6004\/jnccn.2021.0022","volume":"19","author":"AB Benson","year":"2021","unstructured":"Benson AB, D\u2019Angelica MI, Abbott DE, Anaya DA, Anders R, Are C, Bachini M, Borad M, Brown D, Burgoyne A, et al. Hepatobiliary cancers, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(5):541\u201365.","journal-title":"J Natl Compr Canc Netw"},{"key":"3136_CR16","unstructured":"Manufacturer and User Facility Device Experience. (MAUDE) Database. https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfmaude\/search.cfm."},{"issue":"12","key":"3136_CR17","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1016\/j.hrthm.2018.07.013","volume":"15","author":"M Kostrzewa","year":"2018","unstructured":"Kostrzewa M, Tueluemen E, Rudic B, Rathmann N, Akin I, Henzler T, Liebe V, Schoenberg SO, Borggrefe M, Diehl SJ. Cardiac impact of R-wave triggered irreversible electroporation therapy. Heart Rhythm. 2018;15(12):1872\u20139.","journal-title":"Heart Rhythm"},{"issue":"3","key":"3136_CR18","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/jso.26041","volume":"122","author":"CH O\u2019Neill","year":"2020","unstructured":"O\u2019Neill CH, Martin RCG. Cardiac synchronization and arrhythmia during irreversible electroporation. J Surg Oncol. 2020;122(3):407\u201311.","journal-title":"J Surg Oncol"},{"issue":"Suppl 4","key":"3136_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/bju.15948","volume":"131","author":"B Geboers","year":"2023","unstructured":"Geboers B, Scheltema MJ, Blazevski A, Katelaris A, Doan P, Ali I, Agrawal S, Barreto D, Matthews J, Haynes A-M, et al. Median 4-year outcomes of salvage irreversible electroporation for localized radio-recurrent prostate cancer. BJU Int. 2023;131(Suppl 4):14\u201322.","journal-title":"BJU Int"},{"key":"3136_CR20","doi-asserted-by":"crossref","unstructured":"Yilmaz M, Karaaslan M, \u015eirin ME, Aybal H\u00c7, Polat ME, Tonyali S, Hatiboglu G. Salvage irreversible electroporation for locally recurrent prostate cancer after definitive radiotherapy: a systematic review. Prostate Cancer Prostatic Dis. 2024.","DOI":"10.1038\/s41391-024-00926-9"},{"issue":"3","key":"3136_CR21","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41391-023-00783-y","volume":"27","author":"K Zhang","year":"2024","unstructured":"Zhang K, Stricker P, L\u00f6hr M, Stehling M, Suberville M, Cussenot O, Lunelli L, Ng C-F, Teoh J, Laguna P, et al. A multi-center international study to evaluate the safety, functional and oncological outcomes of irreversible electroporation for the ablation of prostate cancer. Prostate Cancer Prostatic Dis. 2024;27(3):525\u201330.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"Suppl 3","key":"3136_CR22","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/1475-925X-14-S3-S3","volume":"14","author":"SP Bhonsle","year":"2015","unstructured":"Bhonsle SP, Arena CB, Sweeney DC, Davalos RV. Mitigation of impedance changes due to electroporation therapy using bursts of high-frequency bipolar pulses. Biomed Eng Online. 2015;14(Suppl 3):S3.","journal-title":"Biomed Eng Online"},{"issue":"8","key":"3136_CR23","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1001\/jamasurg.2022.2230","volume":"157","author":"H Wang","year":"2022","unstructured":"Wang H, Xue W, Yan W, Yin L, Dong B, He B, Yu Y, Shi W, Zhou Z, Lin H, et al. Extended focal ablation of localized prostate cancer with high-frequency irreversible electroporation: a nonrandomized controlled trial. JAMA Surg. 2022;157(8):693\u2013700.","journal-title":"JAMA Surg"},{"key":"3136_CR24","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1475-925X-10-102","volume":"10","author":"CB Arena","year":"2011","unstructured":"Arena CB, Sano MB, Rossmeisl JH, Caldwell JL, Garcia PA, Rylander MN, Davalos RV. High-frequency irreversible electroporation (H-FIRE) for non-thermal ablation without muscle contraction. Biomed Eng Online. 2011;10:102.","journal-title":"Biomed Eng Online"},{"issue":"3","key":"3136_CR25","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1177\/1553350617692202","volume":"24","author":"IA Siddiqui","year":"2017","unstructured":"Siddiqui IA, Kirks RC, Latouche EL, DeWitt MR, Swet JH, Baker EH, Vrochides D, Iannitti DA, Davalos RV, McKillop IH. High-frequency irreversible electroporation: safety and efficacy of next-generation irreversible electroporation adjacent to critical hepatic structures. Surg Innov. 2017;24(3):276\u201383.","journal-title":"Surg Innov"}],"container-title":["BMC Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-025-03136-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12893-025-03136-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-025-03136-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T22:02:18Z","timestamp":1757455338000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcsurg.biomedcentral.com\/articles\/10.1186\/s12893-025-03136-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3136"],"URL":"https:\/\/doi.org\/10.1186\/s12893-025-03136-9","relation":{},"ISSN":["1471-2482"],"issn-type":[{"value":"1471-2482","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"390"}}